封面
市場調查報告書
商品編碼
1392009

止痛貼市場:按類型、按應用、按技術、按劑型、按處方箋、按患者年齡、按黏合特性、按作用時間、按藥物類別、按配銷通路、按地區

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球止痛貼片市場規模為52.9億美元,預計到2030年將達到74.5億美元,2023年至2030年年複合成長率為5%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 52.9億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 5.00% 2030年市場規模預測 74.5億美元
圖 1. 2023 年止痛貼片的全球市場佔有率(按地區分類)
止痛貼市場-IMG1

疼痛貼片也稱為經皮吸收貼片,是一種黏性貼劑,可直接透過皮膚輸送藥物以緩解局部疼痛。這些貼片方便、易於使用,並能長時間控制藥物釋放。由於慢性疼痛疾病的盛行率不斷增加以及對替代疼痛管理療法的需求,疼痛貼片市場在過去十年中經歷了顯著成長。疼痛貼片也稱為經皮治療系統,可將止痛藥透過皮膚輸送到血液中,以緩解局部疼痛。與口服藥物相比,止痛貼的優點包括更穩定地控制體內藥物濃度,避免在肝臟中進行初始代謝,從而降低某些藥物的口服生物利用度。此外,新的藥物傳遞技術可以延長貼片中藥物的釋放時間,從而實現全天候有效的疼痛管理。

市場動態:

疼痛貼片市場主要是由關節炎、下背痛和神經病變疼痛等慢性疼痛疾病的日益普及所推動的。這些情況需要長期的疼痛管理解決方案,而疼痛貼片則提供了一個方便且有效的選擇。此外,人們對口服止痛藥相關潛在風險(例如成癮和胃腸道副作用)的認知不斷提高,導致人們越來越關注止痛貼等非侵入性藥物傳遞系統。

然而,也存在阻礙市場成長的因素。與傳統鎮痛藥相比,止痛貼的成本較高,而且某些地區這些產品的報銷有限,可能會限制市場擴張。此外,疼痛貼片的核准有嚴格的監管要求,與貼片使用相關的皮膚刺激和過敏反應的風險對市場成長構成了挑戰。

儘管有這些挑戰,止痛貼片市場仍存在一些成長機會。疼痛貼片中擴大採用無線連接和感測器整合等先進技術,為創新和產品差異化鋪平了道路。此外,開拓市場尚未開發的潛力以及對個體化疼痛管理解決方案不斷成長的需求為市場參與者提供了擴大其影響力並迎合不同消費群體的機會。

本研究的主要特點

  • 本報告對全球止痛貼片市場進行了詳細分析,並提供了以2022年為基準年的預測期(2023-2030年)的市場規模和年複合成長率(CAGR%)。
  • 它還揭示了各個細分市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數,介紹了全球疼痛貼片市場的主要企業。
  • 該報告的見解將幫助行銷人員和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
  • 全球止痛貼市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球止痛貼市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 對有效緩解疼痛和非侵入性治療的需求不斷成長
    • 皮膚敏感和刺激
    • 個體化疼痛管理的出現
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 止痛貼市場-冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 止痛貼市場,依類型,2018-2030

  • 鴉片類止痛貼
  • 非鴉片類止痛貼

第6章 止痛貼市場,依應用分類,2018-2030

  • 慢性疼痛貼片
  • 急性疼痛貼片

第7章 止痛貼片市場(依技術分類),2018-2030 年

  • 常規給藥貼片
  • 先進的藥物傳輸貼片

第8章 止痛貼市場,按劑型,2018-2030 年

  • 單藥貼劑
  • 聯合治療貼片

第9章 止痛貼市場,依處方箋,2018-2030

  • 處方止痛貼
  • 非處方 (OTC) 止痛貼片

第10章 止痛貼市場,依病患年齡分類,2018-2030 年

  • 成人疼痛貼
  • 兒童用止痛貼

第11章止痛貼片市場(依黏合劑特性),2018-2030 年

  • 防過敏貼片
  • 標準貼片

第12章止痛貼市場,按行動持續時間,2018-2030

  • 短效貼劑
  • 延長發布補丁

第13章止痛貼市場,依藥物類別,2018-2030

  • 非類固醇抗發炎藥貼劑
  • 局部麻醉貼片
  • 其他

第14章止痛貼市場,依配銷通路分類,2018-2030 年

  • 零售藥房
  • 醫院和診所

第15章止痛貼市場,按地區,2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第16章競爭形勢

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

第17章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6204

The global pain patch market size was valued at US$ 5.29 billion in 2023 and is expected to reach US$ 7.45 billion by 2030, grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.29 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.00% 2030 Value Projection: US$ 7.45 Bn
Figure 1. Global Pain Patch Market Share (%), by Region, 2023
Pain Patch Market - IMG1

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period. The pain patches market has seen significant growth over the past decade driven by the increasing prevalence of chronic pain disorders and the need for alternative pain management therapies. Pain patches, also known as transdermal therapeutic systems, work by delivering pain relieving medications through the skin and into the bloodstream providing localized pain relief. The advantages of pain patches over oral medications include steadier control of drug levels in the body and avoidance of the first-pass liver metabolism which can reduce the oral bioavailability of some drugs. New advanced drug delivery technologies are also enabling prolonged and controlled release of medications from these patches for effective around-the-clock pain management.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides an in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Key Players
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Pain Patch Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Pain Patch Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Pain Patch Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Pain Patch Market, By Prescription, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

15. Pain Patch Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals
  • Analyst Views

17. Section

  • Research Methodology
  • About us